Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of ZF2001 (Zifivax) in Children and Adolescents
NCT05109598Phase 2Completed
- Sponsor
- Zhifei Biological
- Start
- Nov 2021
- Primary completion
- Feb 2022
- Modality
- Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of ZF2001 in coronavirus disease 2019 (COVID-19), sponsored by Zhifei Biological. Started Nov 2021; status: completed.
02
Drugs
ZF2001
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05109598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05109598.